← Evidence map

TrialBMC pulmonary medicine2016

Abediterol, a novel long-acting β2-agonist: bronchodilation, safety, tolerability and pharmacokinetic results from a single-dose, dose-ranging, active-comparator study in patients with COPD.

Jutta Beier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 27439370